Neurosense Therapeutics Ltd. (NRSN)
Market Open
12 Jun, 14:51
NASDAQ (CM) NASDAQ (CM) Primary 
XFRA $
0. 73
-0.01
-1.1908%
$
18.75M Market Cap
- P/E Ratio
- Div Yield
33,247 Volume
-0.8 Eps
$ 0.74
Previous Close Investors:
Want to track NRSN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
NRSN Earnings Reports FAQ
What is the earnings per share (EPS) for NRSN?
The current EPS is -0.8.
What is the company's earnings growth rate?
Neurosense Therapeutics Ltd has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Neurosense Therapeutics Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Neurosense Therapeutics Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for NRSN at this time, as Neurosense Therapeutics Ltd has no recent EPS data to calculate it.
